TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
作者:
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);凋亡调节蛋白质类(Apoptosis Regulatory Proteins);病例对照研究(Case-Control Studies);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);儿童(Child);脱氧葡萄糖(Deoxyglucose);女(雌)性(Female);基因敲低技术(Gene Knockdown Techniques);糖酵解(Glycolysis);人类(Humans);咪唑类(Imidazoles);细胞内信号肽和蛋白质类(Intracellular Signaling Peptides and Proteins);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);小鼠(Mice);中年人(Middle Aged);磷酸果糖激酶2(Phosphofructokinase-2);磷酸单酯水解酶类(Phosphoric Monoester Hydrolases);哌嗪类(Piperazines);预后(Prognosis);RNA, 小分子干扰(RNA, Small Interfering);肿瘤细胞, 培养的(Tumor Cells, Cultured);青年人(Young Adult)
DOI
10.1186/s13045-016-0360-4
PMID
27884166
发布时间
2022-03-31
- 浏览38
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文